VivoSense Board of Directors

Colin Bower

VivoSense CEO

Colin Bower

Bower is a leader in healthcare technology with more than a decade of experience developing leading digital health products and bringing them to market in the roles of founder, CEO, commercial leader, and director. With a suite of complementary skills, Bower joined VivoSense to continue our mission of developing and validating real-world clinical measures from digital technologies and delivering these trusted measures as meaningful endpoints in regulated clinical trials. 

Dudley Tabakin

VivoSense Co-Founder and Chief Product Officer

Dudley Tabakin

Dudley is co-founder of VivoSense and a fervent believer in “good data” over “big data” in the development of digital clinical measures from wearable sensor technology. He has a background in sports and gait biomechanics and more than 10 years of experience in wearable sensor data analytics. 

Chris Garabedian

CEO, Xontogeny and Portfolio Manager, PXV Fund

Chris Garabedian

Chris founded Xontogeny in June of 2016 to support multiple promising technologies from early development through clinical proof of concept. In 2017, Chris joined Perceptive Advisors to develop their Venture Fund strategy and is Portfolio Manager of the Perceptive Xontogeny Ventures Fund which supports early stage companies with Series A investments across biotech, medtech and healthtech. 

Marc Cikes

Healthcare Investment Professional, Board Director, MD

Marc Cikes

Marc Cikes is a healthcare investment professional and board director with a medical background. He has more than 12 years of experience as an entrepreneur and senior executive with major swiss healthcare companies, and has worked as an independent advisor for M&A transactions (buy & sell-side) as well as in the startup space. He is currently Managing Director of the Debiopharm Innovation Fund and sits on the board of three companies. 

Lance Myers

VivoSense Co-Founder

Lance Myers

Lance has 20+ years of experience in digital health and has held multiple executive leadership positions over the course of his career. He was the Founding CEO of VivoSense from 2010 - 2014. From 2017 - 2023 he has served as the Head of Data Science at Verily Life Sciences and also leads a cardiovascular innovations business unit.